Summary
The purpose of this study is to evaluate the safety and activity of BPX-601 CAR-T cells in
participants with previously treated advanced solid tumors (prostate) expressing high levels
of prostate stem cell antigen (PSCA). Participants' T cells are modified to recognize and
target the PSCA tumor marker on cancer cells.